Niels Engberding
Niels Engberding, MD, is a cardiologist at National Jewish Health. Dr. Engberding is in the Division of Cardiology and Department of Medicine.
Associate Professor
Division of Cardiology
Department of Medicine
America’s Top Doctors 2019 — Castle Connolly Medical, Ltd.

Special Interests

My clinical interests include all aspects of general cardiology, such as prevention and treatment of arteriosclerosis, hypertension, and metabolic syndrome as well as diseases of the heart muscle, heart valves, and heart rhythm.

Education

Education
Medizinsche Hochschule Hannover, Hanover, Germany, MD
Internships
Pennsylvania State University College of Medicine, Hershey, PA, Internal Medicine
Medizinsche Hochschule Hannover, Hanover, Germany, Internal Medicine and Cardiology
Residency
Pennsylvania State University College of Medicine, Hershey, PA, Internal Medicine
Fellowship
Emory University School of Medicine, Atlanta, GA, Cardiology

Awards & Recognition

2017: Teacher of the year at Grady Memorial Hospital, awarded by Emory Cardiology Fellows, Atlanta, GA
2009: Cardiology Fellow Poster Award, Emory University Research Day, Atlanta, GA
2004: Young Investigator Award, European Society of Cardiology, Munich, Germany

Board Certification

2016: Nuclear Cardiology
2006, 2016: Internal Medicine
2011: Adult Comprehensive Echocardiography
2010: Cardiovascular Disease

Professional Memberships

Fellow, American College of Cardiology (FACC)
Fellow, European Society of Cardiology (FESC)
American Heart Association
American Society of Echocardiography
American College of Physicians
German Cardiac Society

Publications

The bone morphogenic protein inhibitor, noggin, reduces glycemia and vascular inflammation in db/db mice. Koga M, Engberding N, Dikalova AE, Chang KH, Seidel-Rogol B, Long JS, Lassègue B, Jo H, Griendling KK. Am J Physiol Heart Circ Physiol. 2013 Sep 1;305(5):H747-55.

Management of hypertension in women. Engberding N, Wenger NK. Hypertens Res. 2012 Mar;35(3):251-60

Insulin-like growth factor-1 receptor expression masks the antiinflammatory and glucose uptake capacity of insulin in vascular smooth muscle cells. Engberding N, San Martín A, Martin-Garrido A, Koga M, Pounkova L, Lyons E, Lassègue B, Griendling KK. Arterioscler Thromb Vasc Biol. 2009 Mar;29(3):408-15.

Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase. Landmesser U, Engberding N, Bahlmann FH, Schaefer A, Wiencke A, Heineke A, Spiekermann S, Hilfiker-Kleiner D, Templin C, Kotlarz D, Mueller M, Fuchs M, Hornig B, Haller H, Drexler H. Circulation. 2004 Oct 5;110(14):1933-9.

Allopurinol attenuates left ventricular remodeling and dysfunction after experimental myocardial infarction: a new action for an old drug? Engberding N, Spiekermann S, Schaefer A, Heineke A, Wiencke A, Müller M, Fuchs M, Hilfiker-Kleiner D, Hornig B, Drexler H, Landmesser U. Circulation. 2004 Oct 12;110(15):2175-9.

Teaching & Professional Positions

2010 – 2017: Assistant Professor of Medicine (Cardiology), Emory University School of Medicine, Atlanta, GA

Ask a Question through Patient Portal

Sign in to your My National Jewish Health patient portal account to communicate with your care team, manage appointments, and more. Create an Account
 

Contact Information

  • Office: 877.225.5654

 

Locations

  • National Jewish Health Main Campus
    1400 Jackson St.
    Denver, CO 80206

  • National Jewish Health Highlands Ranch
    8671 S Quebec St, Suite 120 Highlands Ranch, CO 80130

Patient Ratings

The Patient Rating score is an average of all responses to care provider related questions on our independent rating system, the Press Ganey Patient Satisfaction Survey. This survey is about the patient care experience and does not address crucial characteristics like medical decision-making, prescribing the best therapy, and patient outcomes.

Responses are measured on a scale of 1 to 5, with 5 being the best score. Learn more about our patient satisfaction survey.
 

Provider showed concern
4.9

Friendliness
4.9

Spoke using clear language
4.9

Provider explained things clearly
4.9

Amount of time spent with you
4.9

Provider included you in decisions
4.9

Confidence in your doctor
4.9

Likelihood of recommending this provider
4.9
 

Comments

Comments are collected in our Press Ganey Patient Satisfaction Surveys. Patients are de-identified to protect confidentiality and patient privacy. Learn more about our patient satisfaction survey.
 

National Jewish Health PatientJune, 2019
was a good meeting of the Doctor, he explain ever question I had.

National Jewish Health PatientJune, 2019
He listened thoroughly. He finally gave my husband and I hope that we'd find an answer with this doctors help.

National Jewish Health PatientJune, 2019
He is probably one of the best doctors I have ever had!

National Jewish Health PatientApril, 2019
*Dr. Engberding is great.

National Jewish Health PatientMarch, 2019
It was a good experience. I feel good about having him for my dr.

National Jewish Health PatientMarch, 2019
again, Dr E is the best !

National Jewish Health PatientMarch, 2019
As stated above, Dr. Engberding has always provided excellent care for me and my wife. We are lucky to have him as our cardiologist.

National Jewish Health PatientFebruary, 2019
*Dr. Engberding listened to and answered my concerns. Anything I asked was important to him. I cannot say enough positive things about *Dr. Engberding. He is extremely knowledgeable & extremely considerate.

National Jewish Health PatientFebruary, 2019
I always have a very good experience at national Jewish hospital.

National Jewish Health PatientJanuary, 2019
he was polite, courteous and educated!

show more